MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Viatris DIO Ratio 2011-2025 | VTRS
Annual DIO Ratio Viatris
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 140 | 140 | 123 | 128 | 127 | 130 | 141 | 137 | 144 | 157 | 143 | 143 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 157 | 123 | 138 |
Quarterly DIO Ratio Viatris
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 160 | 170 | 178 | 160 | - | - | - | 144 | 150 | - | 137 | 140 | 147 | - | 132 | 132 | 144 | - | 275 | 293 | 217 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 293 | 132 | 172 |
DIO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M |  USA |
 |
Canopy Growth Corporation
CGC
|
167 | $ 1.7 | 50.0 % | $ 183 M |  Canada |
 |
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M | USA |
 |
Cronos Group
CRON
|
221 | $ 3.24 | 13.51 % | $ 1.69 B | Canada |
 |
Assertio Holdings
ASRT
|
347 | $ 0.77 | -1.79 % | $ 54.7 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
133 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | USA |
 |
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | USA |
 |
Aurora Cannabis
ACB
|
1.35 K | $ 5.36 | 17.8 % | $ 86.3 M | Canada |
 |
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B | USA |
 |
HEXO Corp.
HEXO
|
703 | - | 2.45 % | $ 38.1 M | Canada |
 |
DURECT Corporation
DRRX
|
460 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
100 | - | - | $ 28.9 M |  Irlanda |
 |
Emergent BioSolutions
EBS
|
176 | $ 11.46 | -2.22 % | $ 587 M | USA |
 |
Evoke Pharma
EVOK
|
995 | $ 10.97 | 0.18 % | $ 36.7 M | USA |
 |
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
366 | $ 21.38 | -0.05 % | $ 2.03 B |  France |
 |
Evolus
EOLS
|
50.3 | $ 6.99 | 1.09 % | $ 433 M | USA |
 |
Harrow Health
HROW
|
80.1 | $ 47.18 | -7.67 % | $ 1.54 B | USA |
 |
China Pharma Holdings
CPHI
|
168 | $ 1.67 | 11.33 % | $ 29.2 M |  China |
 |
cbdMD
YCBD
|
165 | $ 1.18 | 87.31 % | $ 5.09 M | USA |
 |
Bausch Health Companies
BHC
|
172 | $ 6.95 | -0.93 % | $ 2.54 B | Canada |
 |
OrganiGram Holdings
OGI
|
2.83 K | $ 1.88 | 14.72 % | $ 402 M | Canada |
 |
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
239 | $ 2.61 | 4.99 % | $ 36.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
85.9 | $ 4.83 | 1.15 % | $ 636 M | USA |
 |
Pacira BioSciences
PCRX
|
246 | $ 26.28 | 2.14 % | $ 1.22 B | USA |
 |
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | USA |
 |
Jupiter Wellness
JUPW
|
59.7 | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
143 | $ 13.13 | -2.23 % | $ 1.8 B | USA |
 |
ProPhase Labs
PRPH
|
30.1 | $ 0.12 | -15.26 % | $ 1.9 M | USA |
 |
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
28.5 | $ 0.93 | -2.37 % | $ 21.7 M | USA |
 |
OptiNose
OPTN
|
370 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
97.2 | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
117 | $ 3.59 | -3.37 % | $ 4.46 M | USA |
 |
Tilray
TLRY
|
170 | $ 11.86 | 40.68 % | $ 7.33 B | Canada |
 |
TherapeuticsMD
TXMD
|
1.04 K | $ 1.79 | -2.72 % | $ 18.7 M | USA |
 |
Zomedica Corp.
ZOM
|
183 | - | -0.21 % | $ 98 M | USA |
 |
Veru
VERU
|
179 | $ 2.45 | -4.3 % | $ 330 M | USA |